
Resimat 100mg Capsule
Marketer
Resonance Laboratories Pvt Ltd
Salt Composition
Imatinib mesylate (100mg)
Overview Resimat 100mg Capsule
Capsu-100 (100mg) is indicated for various cancers, primarily blood cancers such as chronic myeloid leukemia and acute lymphoblastic leukemia, plus gastrointestinal stromal tumors. Its mechanism involves targeting proteins crucial to cancer cell proliferation and metastasis. Capsu-100 is also employed in dermatofibrosarcoma protuberans and aggressive systemic mastocytosis. Administer with food, consistently at the same time daily for optimal efficacy. Continue treatment as directed by your physician; duration varies based on individual response. Incorrect dosage or overdose can cause severe adverse events. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Frequent side effects include swelling, nausea, vomiting, muscle spasms, musculoskeletal pain, diarrhea, skin rash, tiredness, and stomach pain. Report unexplained rapid weight gain. Regular blood counts and liver function tests may be advised. Avoid driving or mentally demanding tasks if dizziness or blurred vision occur. Inform your healthcare provider of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Resimat 100mg Capsule
No text provided. Please provide the text you would like me to rephrase.
Uses of Resimat 100mg Capsule
Oncological Management
Major Benefits of Resimat 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Resimat 100mg Capsules with a meal.
Common Side effects of Resimat 100mg Capsule:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Resimat 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 100mg Resimat capsule with a meal.
How Resimat 100mg Capsule works:
Resimat 100mg capsules target cancerous cells by inhibiting the bcr-abl tyrosine kinase protein enzyme. This enzyme drives uncontrolled cancer cell growth. By blocking its action, Resimat promotes programmed cell death (apoptosis) in bcr-abl-positive leukemia cells, thus hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Resimat 100mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Resimat 100mg capsules during pregnancy is contraindicated due to confirmed risk to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the hazards. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Resimat 100mg capsules while breastfeeding is likely unsafe. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant. Nursing mothers should discontinue breastfeeding for the duration of treatment and for 15 days following cessation of the medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Resimat 100mg Capsules.
KidneyCAUTION
Individuals with kidney impairment should use Resimat 100mg capsules cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Resimat 100mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Resimat 100mg Capsule :
Omit any missed Resimat 100mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Resimat 100mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Benzanilide derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Kinase inhibitors targeting tyrosine |
